SUN PHARMACEUTICAL INDUSTRIES INC: Lisdexamfetamine Dimesylate Capsules, 40 mg,
Recall reason: Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Distribution: U.S Nationwide.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot #: AD48709, Expiry: 4/30/2026; AD50894, Expiry: 5/31/2026.. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report